- Home
- IKNA vs DIT Comparison
IKNA vs DIT Comparison
Compare IKNA & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKNA
- DIT
- Stock Information
- Founded
- IKNA 2016
- DIT 1981
- Country
- IKNA United States
- DIT United States
- Employees
- IKNA N/A
- DIT N/A
- Industry
- IKNA Biotechnology: Pharmaceutical Preparations
- DIT Food Distributors
- Sector
- IKNA Health Care
- DIT Consumer Discretionary
- Exchange
- IKNA Nasdaq
- DIT Nasdaq
- Market Cap
- IKNA 81.6M
- DIT 78.7M
- IPO Year
- IKNA 2021
- DIT 1995
- Fundamental
- Price
- IKNA $1.45
- DIT $127.46
- Analyst Decision
- IKNA Buy
- DIT
- Analyst Count
- IKNA 2
- DIT 0
- Target Price
- IKNA $3.00
- DIT N/A
- AVG Volume (30 Days)
- IKNA 134.5K
- DIT 195.0
- Earning Date
- IKNA 03-11-2025
- DIT 01-20-2025
- Dividend Yield
- IKNA N/A
- DIT 0.78%
- EPS Growth
- IKNA N/A
- DIT N/A
- EPS
- IKNA N/A
- DIT 5.93
- Revenue
- IKNA $659,000.00
- DIT $2,202,495,291.00
- Revenue This Year
- IKNA N/A
- DIT N/A
- Revenue Next Year
- IKNA N/A
- DIT N/A
- P/E Ratio
- IKNA N/A
- DIT $21.50
- Revenue Growth
- IKNA N/A
- DIT 7.62
- 52 Week Low
- IKNA $1.22
- DIT $117.00
- 52 Week High
- IKNA $1.94
- DIT $205.00
- Technical
- Relative Strength Index (RSI)
- IKNA 36.12
- DIT 50.56
- Support Level
- IKNA $1.45
- DIT $117.00
- Resistance Level
- IKNA $1.53
- DIT $128.00
- Average True Range (ATR)
- IKNA 0.06
- DIT 3.87
- MACD
- IKNA -0.00
- DIT 0.29
- Stochastic Oscillator
- IKNA 23.53
- DIT 45.65
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.